Women with nonmucinous ovarian cancer should be routinely screened for BRCA1/2 mutations, say the Australian authors of groundbreaking research which shows patients with the mutation respond better to treatment than non-carriers.
View the original article here: Ovarian cancer: experts call for genetic screening – Oncology Update
